Carrie Van Der Weyden

10PUBLICATIONS
63CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMedical microbiology not elsewhere classifiedChemotherapyGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 29, 2026
Prime editing enables drug-controllable T-cell therapies with clinical immunosuppression.

|May 14, 2026
On the RAdR in relapsed T-cell lymphoma.

|Jun 25, 2025
Large-cell transformation of mycosis fungoides: Patterns of care and patient outcomes.

Philippa Johnstone, Martin Higgins, H Miles Prince

|May 14, 2025
Assessment of the Tolerability and Optimal Dosing of the Combination of Brentuximab Vedotin and Lenalidomide in Patients With Relapsed or Refractory T-cell Lymphoma: Results of a Single-centre Phase 1 Dose-escalation Study.

Carrie van der Weyden, Mathias Bressel, Amit Khot

|May 01, 2025
Forecasting optimal treatments in relapsed/refractory mature T- and NK-cell lymphomas: A global PETAL Consortium study.

Mark N Sorial, Jessy Xinyi Han, Min Jung Koh

|Oct 31, 2024
Global outcomes and prognosis for relapsed/refractory mature T-cell and NK-cell lymphomas: results from the PETAL consortium.

Jessy Xinyi Han, Min Jung Koh, Leora Boussi

Pageof 2

Frequent Collaborators

6 joint publications

Henry Miles Prince

3 joint publications

Belinda A Campbell

2 joint publications

Manju Sengar

2 joint publications

Thomas E Lew